CHG-2021-0272
New Dosage Strength for Verasenib. Formulation Change for Verasenib — critical change. Impacts 8 markets and 1 variations.
Change Number
CHG-2021-0272
Type
New Dosage Strength
Product
Status
Overdue
Owner
Priya Sharma
Initiated
2022-07-23
Description
Formulation Change for Verasenib — critical change
Impacted Markets (8)
FR — FranceES — SpainNL — NetherlandsKR — South KoreaIN — IndiaMX — MexicoPL — PolandDK — Denmark
Impacted Modules
3.2.S3.2.P5.3.53.2.P.3
Linked Variations (0)
| Variation # | Type | Application | Status | Submitted | Approved |
|---|